Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026 - The Guardian
- Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026 The Guardian
- Novo Nordisk Warns of First Sales Drop Since Start of Ozempic The New York Times
- Lilly and Novo Whipsaw Wall Street With Split in Obesity Outlook Bloomberg.com
- Novo Shares Tumble on Forecast for Steep Drop in Sales Yahoo Finance
- Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 CNBC